Richardson B P, McDaniel M L, Lacy P E
Diabetes. 1975 Sep;24(9):836-41. doi: 10.2337/diab.24.9.836.
The effects of cyproheptadine on basal and glucose-induced insulin release by isolated rat islets was studied by use of a perifusion system. A forty-five minute preincubation of islets with a medium containing both 34.3 mug./ml. (10(-4) M) cyproheptadine and 1.0 mg./ml. glucose completely abolished the biphasic pattern of increased insulin secretion normally obtained after islets are stimulated with a medium containing 3.0 mg./ml. glucose. In another series of experiments, similar results were obtained when the cyproheptadine and 3.0 mg./ml. glucose were presented together. Here, however, the inhibition of the first phase of insulin secretion did not achieve statistical significance and some recovery of the islets' secretory capacity was observed late during the second phase. In studies designed to investigate the influence of cyproheptadine on basal insulin secretion, no obvious effect was observed. These results are discussed in relation to the species-specific alterations in pancreatic beta-cell morphology that have been reported in rats after the oral administration of cyproheptadine.
采用灌流系统研究了赛庚啶对离体大鼠胰岛基础胰岛素释放及葡萄糖诱导的胰岛素释放的影响。胰岛在含有34.3微克/毫升(10⁻⁴摩尔/升)赛庚啶和1.0毫克/毫升葡萄糖的培养基中预孵育45分钟后,再用含有3.0毫克/毫升葡萄糖的培养基刺激,完全消除了正常情况下所出现的胰岛素分泌增加的双相模式。在另一系列实验中,当赛庚啶与3.0毫克/毫升葡萄糖同时存在时,也得到了类似结果。不过,在此情况下,胰岛素分泌第一相的抑制未达到统计学显著水平,且在第二相后期观察到胰岛分泌能力有一定恢复。在旨在研究赛庚啶对基础胰岛素分泌影响的实验中,未观察到明显作用。结合口服赛庚啶后大鼠胰腺β细胞形态出现的种属特异性改变对这些结果进行了讨论。